Abstract:
An intraocular lens insertion device having a configuration in such a manner that, with the displacement of a haptic toward the convex side of an optical portion, which can be deformed in a curved shape, restricted by an engaging part provided to the tip part of a plunger, the haptic is deformed in a curved shape in the direction in which the haptic approaches the optical portion. The configuration allows, when the intraocular lens is pushed out by the plunger, the haptic to enter a gap formed on the concave side of the optical portion which has been deformed in a curved shape.
Abstract:
Provided is a technology for suppressing discoloration of a halo-isoquinoline derivative-containing aqueous composition during high-temperature storage. Provided is an aqueous composition containing a compound of formula (1): wherein X is a halogen atom, a salt of the compound, or a solvate of the compound or the salt; and a carbonic anhydrase inhibitor.
Abstract:
The present invention provides a compound useful in the prevention and treatment of nonalcoholic fatty liver disease. The invention relates to a drug for the prevention and/or treatment of nonalcoholic fatty liver disease, the drug having as an active ingredient (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate of these.
Abstract:
To provide a method for improving optical purity of an optically active 2-hydroxycarboxylic acid or a derivative thereof, which is useful as a raw material in the manufacture of medicines, agrochemicais, and industrial products. The method of the invention for improving purity of a hydroxycarboxylic acid of the following formula (1a) or (1b) or a derivative thereof includes the steps of reacting the hydroxycarboxylic acid of the following formula (1a) or (1b) with at least one optically inactive base selected from the group consisting of an alkali metal, alkoxide and a secondary amine in the presence of a solvent and, subsequently, performing recrystallization, to thereby form a hydroxycarboxylic acid salt of the following formula (IIIa) or (IIIb): wherein R1 represents a C1-8 alkyl group, and R2 represents an alkali metal or a secondary amine.
Abstract:
An average image producing means 52 produces an average image from all or some of a plurality of images captured at the same location. A noise extracting means 53 extracts a noise pixel on the basis of the result of a comparison between the pixel values of the pixels in the captured images and the pixel values of the pixels at the same position in the average image. An interpolating means 54 interpolates the pixel value of the noise pixel included in the captured images using the pixel values of other pixels to produce a noise-eliminated image.
Abstract:
The intraocular lens insertion tool includes a nozzle main body having a nozzle portion 15, a stage portion capable of disposing the intraocular lens 2 in the nozzle main body, and a plunger 60 that presses the intraocular lens 2 set in the stage portion by a leading end, thereby releasing the intraocular lens 2 into an eyeball. The leading end portion 10a of the nozzle portion 15 is obliquely cut so that, as it goes to the front side from the optical axis rear side of intraocular lens 2, the position of the end surface is located on the front side, and at the leading end 61d of the plunger 60, a protruding portion 61e is provided which protrudes to the front side so as to be able to place the surface of the optical axis rear side of the intraocular lens 2.
Abstract:
Provided is a technique for achieving a higher measurement accuracy in the detection of an organism-originated physiologically active substance or the measurement of the concentration of the organism-originated physiologically active substance in a hyaluronic acid preparation. The present invention relates to a measurement method for detecting an organism-originated physiologically active substance or measuring the concentration of the organism-originated physiologically active substance in a hyaluronic acid preparation by mixing the hyaluronic acid preparation with an AL reagent to allow the organism-originated physiologically active substance in the hyaluronic acid preparation and an AL to react with each other. A mixed solution of the hyaluronic acid preparation with the AL reagent is diluted with an aqueous electrolyte solution, and a specific protein having a higher affinity for the organism-originated physiologically active substance than that of hyaluronic acid is added to the mixed solution.
Abstract:
A lens barrel has a telescopic structure in which an inner barrel and an outer barrel move relative to each other. A plurality of ring retainers (201 and 202) are disposed at different positions with respect to the optical axis direction between an inner barrel (11) and an outer barrel (12) to support a number of bearing balls (30) so that the bearing balls (30) roll in contact with the inner barrel (11) and the outer barrel (12). The retainers (201 and 202) are supported floatingly in a direction parallel to the optical axis in accordance with the rolling movement of the bearing balls (30). The inner barrel (11) and the outer barrel (12), which move relative to each other, are supported by the ball bearings.
Abstract:
A supporter includes a body section having a back-contact section, a first auxiliary band section of which one end is fixed to the top end of a left side of the back-contact section and the other end is fixed to the bottom end of a right side of the back-contact section, a second auxiliary band section forming a pair with the first auxiliary band section, a first ring arranged to slide between the one end and the other end of the first auxiliary band section, a second ring forming a pair with the first ring, a first adjustment band section of which one end is fixed to loops on a right end side of the body section and the other end can be fastened to loops on the right end side of the body section, and a second adjustment band section forming a pair with the first adjustment band section.